home / stock / plse / plse quote
Last: | $7.82 |
---|---|
Change Percent: | -0.5% |
Open: | $8.09 |
Close: | $7.82 |
High: | $8.23 |
Low: | $7.73 |
Volume: | 169,447 |
Last Trade Date Time: | 05/03/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$7.82 | $8.09 | $7.82 | $8.23 | $7.73 | 169,447 | 05-03-2024 |
$8.05 | $7.71 | $8.05 | $8.42 | $7.52 | 179,846 | 05-02-2024 |
$7.6 | $7.35 | $7.6 | $7.81 | $7.19 | 129,197 | 05-01-2024 |
$7.37 | $7.11 | $7.37 | $7.77 | $7.07 | 195,730 | 04-30-2024 |
$7.25 | $7.23 | $7.25 | $7.69 | $7.15 | 161,684 | 04-29-2024 |
$7.19 | $6.71 | $7.19 | $7.21 | $6.65 | 71,325 | 04-26-2024 |
$6.69 | $6.69 | $6.69 | $6.78 | $6.595 | 117,307 | 04-25-2024 |
$6.86 | $6.92 | $6.86 | $6.935 | $6.67 | 129,153 | 04-24-2024 |
$6.86 | $6.86 | $6.86 | $7.05 | $6.81 | 123,845 | 04-23-2024 |
$6.85 | $7.3 | $6.85 | $7.3 | $6.73 | 94,131 | 04-22-2024 |
$7.19 | $7.26 | $7.19 | $7.59 | $6.8134 | 180,938 | 04-19-2024 |
$7.36 | $7.39 | $7.36 | $7.53 | $7.275 | 147,946 | 04-18-2024 |
$7.47 | $7.87 | $7.47 | $7.87 | $7.38 | 149,671 | 04-17-2024 |
$7.78 | $7.75 | $7.78 | $7.86 | $7.45 | 113,563 | 04-16-2024 |
$7.82 | $7.27 | $7.82 | $8.23 | $7.24 | 328,356 | 04-15-2024 |
$7.22 | $7.15 | $7.22 | $7.31 | $6.97 | 133,963 | 04-12-2024 |
$7.26 | $7.42 | $7.26 | $7.5962 | $6.94 | 233,990 | 04-11-2024 |
$7.41 | $7.24 | $7.41 | $7.6191 | $7.1107 | 137,653 | 04-10-2024 |
$7.53 | $7.52 | $7.53 | $7.71 | $7.47 | 120,182 | 04-09-2024 |
$7.52 | $7.71 | $7.52 | $7.74 | $7.3977 | 172,379 | 04-08-2024 |
News, Short Squeeze, Breakout and More Instantly...
Pulse Biosciences Inc Company Name:
PLSE Stock Symbol:
NASDAQ Market:
Pulse Biosciences Inc Website:
Pulse Biosciences, Inc. (Nasdaq: PLSE) (“Pulse” or the “Company”), a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablation™ (nsPFA™) technology, today announced that the Company’s Board of Directors has set the ...
2024-04-25 21:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablation™ (nsPFA™) technology, today announced it will report financial results for the first quarter 2024 after market close on Tuesday, May 7, 2024. Company ...